Purpose: To test the efficacy of 7T MRS for in vivo detection of 2-hydroxyglutarate (2HG) in brain tumors. Methods: The subecho times of point-resolved spectroscopy (PRESS) were optimized at 7T with density-matrix simulations and phantom validation to improve the 2HG signal selectivity with respect to the neighboring resonances of g-aminobutyric acid (GABA), glutamate (Glu), and glutamine (Gln). MRS data were acquired from 12 subjects with gliomas in vivo and analyzed with LCModel using calculated basis spectra. Metabolite levels were quantified using unsuppressed short echo time (TE) water as a reference. Results: The PRESS TE was optimized as TE ¼ 78 ms (TE 1 ¼ 58 ms and TE 2 ¼ 20 ms), at which the 2HG 2.25 ppm resonance appeared as a temporally maximum inverted narrow peak and the GABA, Glu, and Gln resonances between 2.2 and 2.5 ppm were all positive peaks. The PRESS TE ¼ 78 ms method offered improved discrimination of 2HG from Glu, Gln, and GABA when compared with short-TE MRS. 2HG was detected in all patients enrolled in the study, the estimated 2HG concentrations ranging from 1.0 to 6.2 mM, with percentage standard deviation of 2%-7%. Conclusion: Data indicate that the optimized MRS provides good selectivity of 2HG from other metabolite signals and may confer reliable in vivo detection of 2HG at relatively low concentrations. Magn Reson Med 77:936-944,
INTRODUCTION
Mutations in the isocitrate dehydrogenase (IDH) 1 and 2 enzymes of the tricarboxylic acid cycle cause NADPH-dependent reduction of a-ketoglutarate to 2-hydroxyglutarate (2HG), resulting in a two-to-three orderof-magnitude increase in the cellular 2HG concentration, which otherwise is present at very low levels in normal conditions (1) (2) (3) . This coincides with loss of catalytic activities of mutated IDH to convert isocitrate to aketoglutarate (1, 4) . These modifications of metabolic activities have become a hallmark of cancer and are strongly implicated in tumorigenesis (5) . Moreover, IDH mutations, which occur in the majority of World Health Organization grade II and III gliomas and secondary glioblastomas, are associated with longer overall survival compared with IDH wild-type tumors (6, 7) . Noninvasive in vivo detection of 2HG may therefore provide new insight into tumor transformation and development of therapeutic targets.
The 2HG molecule has five nonexchangeable protons, which resonate at 4.02, 2.27, 2.22, 1.98, and 1.83 ppm (Fig. 1a) (8) . These protons are J-coupled and give rise to multiplets at 4.02, 2.25, and $1.90 ppm in vivo. Precise measurement of 2HG by standard short-TE MRS is challenging due to extensive spectral overlaps. The 2HG 4.02 ppm signal is obscured by the creatine (Cr) 3.92 ppm and myo-inositol (mI) 4 .06 ppm resonances. Detection of the 2HG 1.9 ppm signal is challenging due to its proximity to the N-acetylaspartate (NAA) singlet at 2.01 ppm. The 2HG signal at 2.25 ppm, which is larger than the other 2HG signals, is overlapped with the resonances of glutamate (Glu), glutamine (Gln), and g-aminobutyric acid (GABA). Several studies have recently reported in vivo detection of 2HG in patients with gliomas at 3T, achieved by means of optimized-TE point-resolved spectroscopy (PRESS) (9,10), J-difference editing (9, 11) , correlation spectroscopy (11) , and standard short-TE MRS (12) . Given the role of 2HG as a diagnostic and prognostic imaging biomarker, in vivo measurement of 2HG is of high significance, but accurate evaluation of 2HG in vivo remains challenging, especially when 2HG elevation is moderate.
High-field MRS benefits from enhancement of spectral resolution and signal gain. At 7T, which is increasingly available for patient studies, short-TE MRS is widely used due to its advantage of minimal T 2 signal loss. However, the spectral analysis for 2HG may be complicated by the presence of the broad complex signals from macromolecules (MM) at short TE. Because the MM signals diminish rapidly with TE, a long-TE approach can be employed as an alternative, with the additional advantage that TE optimization may improve discrimination between J-coupled spin resonances. Specifically, as shown in prior 7T MRS studies (13) (14) (15) , the spectral resolution of the GABA, Glu, and Gln resonances between 2.2 and 2.5 ppm can be improved at carefully chosen long echo times, largely due to the effects of multiplet narrowing and in part due to the spectral simplification arising from the attenuated MM signals. Preliminary studies of 2HG detection using long TEs (78-110 ms) at 7T were recently reported (16) (17) (18) (19) . Here we report a 1 H MRS method for detecting 2HG in gliomas at 7T, which provides improved selectivity of 2HG against neighboring resonances, compared with short-TE approaches. A long PRESS echo time is developed for good differentiation of the 2HG 2.25 ppm resonance from the Glu, Gln, and GABA signals. Preliminary in vivo data from 12 glioma patients are presented.
METHODS
To improve the detectability of 2HG signal at 2.25 ppm with respect to the neighboring resonances of GABA, Glu, and Gln, the echo time of PRESS was optimized with density-matrix simulations that incorporated experimental radiofrequency (RF) and gradient pulse waveforms. Two-dimensional (2D) volume-localized spectra were calculated for the first and second subecho times of PRESS, TE 1 , and TE 2 , in the range of 12-90 ms (with 1-ms increments), using a product operator-based transformation-matrix algorithm described previously (9) . Volume localization was obtained with an 8.8-ms 90 RF pulse (bandwidth ¼ 4.7 kHz) and two 12-ms 180 RF pulses (bandwidth ¼ 1.4 kHz) at an RF field intensity (B 1 ) of 15 mT. Published chemical shift and J-coupling constants were used for the simulations (8, 20, 21) . The computer simulation was programmed with MATLAB (MathWorks, Natick, Massachusetts, USA).
Twelve patients with brain tumors were recruited for the study. Six patients had postscan surgical biopsies, and six patients had mass lesions clinically consistent with a grade 2 or 3 glioma. The tumor grades and types were determined by the histopathological analysis of biopsied tissue according to World Health Organization criteria. IDH mutational status was obtained with immunohistochemical analysis and genomic sequencing. Written informed consent was obtained from each patient before the MR scans. The study was approved by the Institutional Review Board at the University of Texas Southwestern Medical Center.
MR experiments were performed on a human wholebody 7T MR scanner (Philips Medical Systems, Cleveland, Ohio, USA) using a quadrature transmit (4 kW RF amplifier) and 16-channel receive head coil (Nova Medical, Wilmington, Massachusetts, USA). The optimized PRESS sequence was tested in two spherical phantoms (6 cm diameter; pH ¼ 7.0); one with 2HG (12 mM) and glycine (Gly) (20 mM) , and the other with 2HG (5 mM), GABA (1 mM), Glu (5 mM), Gln (5 mM), and Cr (10 mM (22) . Surgical cavities, areas of intratumoral hemorrhage, cystic changes, and necrosis identified on T 2w -FLAIR anatomical images were excluded from the tumor voxels.
The 16-channel data were combined using a scanner built-in function in seven patients and using an in-house MATLAB script in five patients that was developed according to a published algorithm (23) . Free-induction decay signals were multiplied by a 1-Hz exponential function to prior to Fourier transformation. Spectral fitting was undertaken with LCModel (version 6.3; Stephen Provencher, Oakville, Ontario, Canada) (24) using numerically calculated basis spectra of 20 metabolites: 2HG, GABA, Glu, Gln, NAA, N-acetylaspartylglutamate, tCr (creatine þ phosphocreatine), tCho (glycerophosphocholine þ phosphocholine), glutathione, myo-inositol, glycine, lactate, taurine, scyllo-inositol, aspartate, phosphoethanolamine, ethanolamine, citrate, succinate, and threonine. The spectral fitting was conducted between 0.5 and 4.1 ppm. For validation purposes, additional LCModel spectral fitting was performed without 2HG in the basis set. Cram er-Rao lower bounds (CRLB) and individual metabolite fits were obtained from LCModel. For evaluation of the Glu, tNAA, tCr, and tCho concentrations, the transverse relaxation effects were corrected using published healthy brain T 2 values of 120, 150, 110, and 140 ms, respectively (14, 25) . The T 2 values of 2HG, GABA, and Gln were assumed to be equal to the Glu T 2 values. Metabolite concentrations were calculated with reference to water at 43 M, whose signal strength was evaluated from LCModel fitting using a STEAM water basis set.
Statistical tests were performed for potential correlation of 2HG levels with Glu, Gln, GABA, tCho, and tNAA concentrations using Minitab (Minitab, State College, Pennsylvania, USA). Statistical significance was declared at P ¼ 0.05, and data are presented as the mean 6 standard deviation.
RESULTS
The PRESS volume-localized density-matrix simulation indicated that the 2HG 2.25-ppm signal from the strongly coupled C4 proton spins depends on the PRESS subecho times, TE 1 and TE 2 , extensively (Fig. 1b) . The 2.25-ppm signal, which was positive at short TE (TE 1 þ TE 2 < 40 ms), shrank substantially at a TE value of approximately 60 ms, then grew larger but negative with increasing TE (Supporting Fig. S1 ). The dependence of the 2HG signal intensity and pattern on TE 1 and TE 2 was asymmetric with respect to the TE 1 ¼ TE 2 line. At PRESS (TE 1 , TE 2 ) ¼ (58, 20) ms, the 2HG 2.25-ppm signal was temporally maximum with negative polarity. For an identical volume, ignoring T 2 relaxation effects, the 2HG 2.25-ppm signal amplitude at TE ¼ 78 ms was 56% with respect to a 90 pulse-and-acquire sequence (data not shown) and 92% compared with PRESS TE ¼ 24 ms (Fig. 1b-1d ), which was the shortest possible TE in the simulation. Most importantly, using the PRESS TE ¼ 78 ms sequence resulted in apparent line narrowing of the 2HG multiplet. For broadening to a singlet line width of 9 Hz, the width of the 2HG 2.25 ppm multiplet using the PRESS TE ¼ 78 ms sequence was 8.2 Hz, much smaller than those of pulse-acquisition (23.7 Hz) and PRESS TE ¼ 24 ms (31.2 Hz). Apparent multiplet narrowing also occurred to the signals of GABA, Glu, and Gln between 2.2 and 2.5 ppm, assuring improved spectral resolution between 2HG, GABA, Glu, and Gln ( Fig. 1c and 1d ). The 2HG and GABA signals, which are very proximate to each other, were predicted to be separable even when the peaks were broadened (Supporting Fig. S2 ). Taken together, the PRESS echo time was optimized as TE ¼ 78 ms (TE 1 ¼ 58 ms and TE 2 ¼ 20 ms) for 2HG detection in the present study.
The 2HG-optimized PRESS TE ¼ 78 ms method was tested in a phantom solution with 2HG and Gly (Fig. 2) . Ganji et al.
The signal strengths and patterns of the 2HG resonances were all in good agreement between calculation and experiment. The phantom data showed an inverted peak of 2HG at 2.25 ppm, as predicted by the simulation. The prepared 2HG-to-Gly concentration ratio of 0.6 (12/20) was reproduced within experimental errors ($5%), following the correction for the transverse relaxation effects in the solution using experimentally measured phantom T 2 values (Gly T 2 ¼ 1500 ms and 2HG T 2 ¼ 650 ms). Figure 3 shows a spectrum from a composite phantom with 2HG, GABA, Glu, and Gln, together with the LCModel fit. The phantom spectrum and the fit agreed closely. The prepared concentrations were well reproduced by the spectral fitting, which resulted in concentrations of 2HG, GABA, Glu, and Gln (with respect to Cr at 10 mM) as 5.0, 1.0, 5.3, and 4.7 mM, respectively, after correction for the T 2 relaxation effects in 2HG, GABA, Glu, and Gln using the phantom 2HG T 2 value. In addition, we tested the 2HG-optimized PRESS sequence in a healthy brain. The data from three regions (frontal, occipital, and midbrain) showed the expected metabolite signals without evidence of 2HG (Supporting Fig. S3 ). Figure 4 presents an in vivo spectrum, obtained with the 2HG-optimized PRESS TE ¼ 78 ms method, from a subject with IDH1-mutated oligoastrocytoma, in which T 2 w-FLAIR imaging identified a left mesial temporal lobe mass. The spectrum showed a large inverted peak at 2.25 ppm, which was closely reproduced by the LCModel fit when using a basis set with 2HG (Fig. 4a) . The 2HG level was estimated to be 6.2 mM, with high precision (CRLB ¼ 2%). The estimates of GABA, Glu, and Gln were 0.4, 1.2, and 3.1 mM, respectively, with CRLB at 23%, 9%, and 6%, respectively. The concentration of tCho, whose level in healthy brain may be 1-1.5 mM (14, 26) , was moderately increased in this tumor (1.8 mM). When 2HG was excluded from the basis set, the resulting fit was substantially different from the in vivo In Vivo Detection of 2-Hydroxyglutarate at 7T spectrum at approximately 2.25 and 4.0 ppm (Fig. 4b) . The fitting resulted in large residual signals at 2.25 and approximately 4.0 ppm and some change in the LCModel baseline at >3.5 ppm, indicating that the signals at the two spectral locations were primarily attributed to the 2HG H4 and H2 resonances. The absence of 2HG in the basis set influenced the estimation of other metabolites, such as GABA and Glu, whose major signals are close to 2.25 ppm.
The 2HG detectability of the PRESS TE ¼ 78 ms sequence was compared with short-TE MRS. Figure 5 presents in vivo spectra from a radiography-suggested glioma patient, obtained with the PRESS and STEAM TE ¼ 13 ms methods. The PRESS spectrum showed a relatively small but clearly discernible negative peak at 2.25 ppm, whereas the STEAM data had a smoothly varying signal pattern between 2.1 and 2.4 ppm, most likely due to the overlaps of the broad peaks from several metabolites, macromolecules, and lipids. In the spectral fitting with 2HG in the basis set, the PRESS and STEAM spectra were both well reproduced by LCModel fits, without showing large residuals at 2.25 ppm (Fig.  5a and 5c ). Following correction for T 2 relaxation effects, the estimated 2HG concentration was slightly different between PRESS and STEAM (2.9 versus 2.4 mM), whereas the tCho estimates were about the same (2.5 versus 2.7 mM). The CRLB of 2HG was considerably smaller in PRESS than in short-TE STEAM (6% versus 12%). When 2HG was removed from the basis set, the fitting outputs from the PRESS and STEAM data were quite different. The without-2HG fitting of the PRESS data left an inverted peak at 2.25 ppm in the residual spectrum. In contrast, in the STEAM data, the residuals at $2.25 ppm were featureless for both the with-2HG and without-2HG fittings, indicating that the 2HG signal from the with-2HG fitting was not very selective. In addition, estimates of GABA, Glu, and Gln were influenced by the removal of 2HG from the basis set in both PRESS and STEAM. Table 1 presents the estimated concentrations and CRLBs of 2HG, GABA, Glu, Gln, tCho, and tNAA for the 12 tumor patients enrolled in the study (six with mutated IDH and six whose IDH status was unknown). For these 12 patients, the mean concentration of 2HG was 3.1 6 1.7 mM with a mean CRLB of 5% 6 2%. For the six patients with biopsy-proven IDH mutation, the mean 2HG level was 3.3 6 2.0 mM (range, 1.0-6.2 mM). Similar 2HG concentrations were obtained in the six prebiopsy patients, with a mean 2HG level at 2.9 6 1.5 mM (range, 1.0-4.4 mM). In addition, we evaluated the potential correlation of 2HG levels with tumor grade and the concentrations of tCho, tNAA, Glu, Gln, and GABA. Significant correlation was observed between 2HG and Gln (P ¼ 0.03).
DISCUSSION
In the current study, we measured the onco-metabolite 2HG at 7T in vivo. Given that the 2HG 2.25-ppm resonance, which yields the most pronounced signal in 2HG, is extensively overlapped with the neighboring resonances of GABA, Glu, and Gln at short TE (see Figs. 1c and 5c), a long TE approach has been developed for detection of 2HG and tested in glioma patients in vivo. The in vitro and in vivo data show clearly that the 2HG-optimized PRESS TE ¼ 78 ms method brings about apparent multiplet narrowing in 2HG as well as GABA, Glu, and Gln, as predicted by the numerical simulation, and thus provides improved selectivity of 2HG with respect to the neighboring resonances, compared with short-TE MRS. Moreover, the 2HG 2.25-ppm peak polarity is inverted at the optimized PRESS TE, giving further possibility of 2HG signal differentiation from the adjacent positive signals of GABA and Glu. Using the optimized-TE MRS at 7T, 2HG was measurable in all of the 12 IDHmutated and/or radiography-suggested glioma patients, of which four tumors had relatively low 2HG concentrations (<2 mM) that were obtained with acceptable precision (CRLB 7%).
Despite the similarity in molecular structure, the J evolution of the 2HG resonances appears to be quite different than those of the Glu and Gln spins at 7T, resulting in the negative polarity of the 2.25-ppm multiplet of 2HG at TE ¼ 60 À 100 ms, whereas the polarity of the Glu and Gln multiplets between 2.3 and 2.5 ppm remains positive for the TEs studied. For each 2HG, Glu and Gln, the five non-exchangeable protons (ie, H2, H3, H3 0 , H4, and H4 0 ) may be modeled as AMNPQ, of which the C4 proton spins (H4 and H4 0 ), P and Q, that yield signals between 2.2 and 2.5 ppm, are strongly coupled with the C3 protons. Following the 90 excitation, the inphase coherences, -P y and -Q y , evolve to antiphase coherences over time. The strength and pattern of the C4 proton multiplet may then be determined by the four inphase coherences (ie, P x , P y , Q x , and Q y ) and 28 antiphase coherences, which include 14 terms of P-spin magnetization in antiphase with respect to Q, M, and/or N spins (eg, 2P x Q z , 4P y Q z M z , 8P x Q z M z N z , etc.) and 14 terms of Q-spin magnetization in antiphase with respect to P, M, and/or N spins (eg, 2Q y P z , 4Q x P z M z , 8Q y P z M z N z , etc.). A PRESS volume-localized numerical simulation indicates that, when the absorption signal of an uncoupled spin I is given by -I y , the C4 proton signals of Glu and Gln at TE ¼ 78 ms are mainly attributed to 4P y M z N z and 4Q y M z N z coherences ($90%), with coefficients at 0.54 and 0.58, respectively, for Glu and 0.3 and 0.31, respectively, for Gln. In contrast, the 2HG 2. The 2HG signal strength and pattern depends on the PRESS 180 RF pulses. For the 180 pulse envelope used in the present study (see Fig. 1d of reference (10) ), the pattern of the C4 proton multiplet is not sensitive to the bandwidth of PRESS 180 RF pulses due to the relatively small spectral distance between the C4 and C3 protons (<0.5 ppm), but the peak amplitude is somewhat dependent on the bandwidth. A computer simulation indicates that, for bandwidths of 1.4, 2.8, and 5.6 kHz (with durations of 12, 6, and 3 ms, respectively), the 2HG 2.25-ppm signal amplitude for the PRESS TE ¼ 78 ms sequence relative to a 90 pulse-and-acquire sequence Abbreviations: A, astrocytoma; AA, anaplastic astrocytoma; AOA, anaplastic oligoastrocytoma; G2, grade 2 glioma; G3, grade 3 glioma; IDH1, IDH1-mutated glioma; IDH2, IDH2-mutated glioma; O, oligodendroglioma; OA, oligoastrocytoma.
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was 56%, 60%, and 64% for an identical volume, respectively ( Fig. 6a-6c ). Unlike the C4-proton resonances, the intensity and pattern of the C3 and C2 proton multiplets of 2HG both depend on bandwidth due to the large spectral distance between the coupling partners. In addition, for a 180 RF pulse with a different envelope (see Fig. 1b of reference (10) ), whose bandwidth is, with a duration of 6.2 ms, the same as that of the 180 pulse of the present study (1.4 kHz), the 2HG 2.25-ppm signal at PRESS (TE 1 , TE 2 ) ¼ (58, 20) ms was quite small (27% with respect to 90 acquisition) (Fig. 6d) . For this pulse, the 2HG 2.25-ppm signal was maximized at (TE 1 , TE 2 ) ¼ (54, 27) ms, but the amplitude was only 31% relative to 90 acquisition (Fig. 6e) . Taken together, the 2HG 2.25-ppm multiplet from the strongly coupled C4 proton spins depends on the 180 RF pulse bandwidth, duration, and envelope. Because the spectral pattern and signal yield depend on the RF pulses, basis spectra generated with actual RF pulse envelopes may be required for spectral fitting.
The detectability of 2HG may depend on line width and signal-to-noise ratio (SNR). The mean in vivo line width (full-width half-maximum) of the tCho singlet in our data from 12 patients was 11 6 2.0 Hz, similar to that reported in our previous study (14) . To evaluate the influence of line width on 2HG detection, we performed LCModel analyses on simulated spectra with random noise for singlet line widths of 5-20 Hz. The spectra included 2HG, GABA, Glu, Gln, and Cr at a concentration ratio of 5:1:5:5:5, with 2HG SNR (ie, peak amplitude to noise standard deviation ratio) at 10 for the various line widths. The results indicated that the 2HG-to-Cr concentration ratio of unity was closely reproduced up to a singlet line width of approximately 15 Hz, which is much larger than the mean in vivo line width of this study. In addition, LCModel fitting was performed on similar synthetic data for evaluating SNR dependence of 2HG detectability. For a singlet line width of 11 Hz, the 2HG-to-Cr ratio of unity was reproduced in spectral fitting when the 2HG SNR was !2. In the in vivo data of the present study, the mean 2HG SNR was 8.9 6 5.9, which is much higher than the theoretical SNR limit for proper 2HG detection. The results from the analyses of the synthetic data may support the reliable detection of 2HG at low concentrations (<2 mM) using our proposed MRS method.
Signal reduction due to T 2 relaxation effects may be a major pitfall of the proposed method. The 2HG signal could decay by approximately 50% during the TE ¼ 78 ms for T 2 ¼ 120 ms, which was used for T 2 signal loss correction in this study. The disadvantage may be outweighed by improved resolution of the 2HG signal, which is achieved by the optimized long TE. Suppression of MM signals at the long TE may be another benefit for enhancing intermetabolite discrimination. Although a long-TE acquisition may provide enhanced resolution, a caveat with respect to 2HG quantification is that the measured signal intensity depends on the accuracy of 2HG T 2 . In addition, the B 1 field is relatively inhomogeneous at 7T, thus extension of the proposed PRESS method to spectroscopic imaging of 2HG may not be straightforward. Although the B 1 variation within a small volume may not be extensive (Supporting Fig. S4 ), imaging of metabolites in large volumes often suffers from B 1 inhomogeneity. Reliable spectroscopic imaging of 2HG may require B 1 shimming with multichannel RF transmission (27) and/or use of adiabatic RF pulses for obtaining uniform flip angles across a large volume of interest (19) .
Several sources of errors may be present in the present study. First, the use of the healthy brain Glu T 2 value for correcting for the T 2 relaxation effects of 2HG, GABA, Glu, and Gln in tumors may introduce errors in the quantification, depending on the differences of their T 2 (10)). Spectra were broadened to a Cr singlet of 9 Hz. The singlet strength in panels d and e was smaller by approximately 10% compared with that of panels a-c due to the difference in ripple size in the refocusing profiles.
values from the Glu T 2 . In addition, potential differences of T 2 between healthy brain and tumors will cause errors in metabolite estimation, but we believe these errors may not be substantial, because metabolite T 2 differences between tumors and healthy brain are not extensive (28) . Second, differences in T 1 saturation effects on metabolites and water signals, which were ignored in this study, could introduce error in metabolite quantification.
Third, some errors may be present due to the effects of chemical-shift misregistration. The slice displacements due to the limited bandwidth (1.4 kHz) of the 180 RF pulse was quite large at 7T ($20% of the slice thickness per ppm), preventing acquisition of multiple resonances from an identical volume. The metabolite concentrations may be inhomogeneous in heterogeneous tumors. Our estimates of metabolites represent the concentrations in voxels shifted according to the spectral distances of the metabolite resonances from the RF carrier frequency (2.5 ppm). Fourth, use of STEAM water for quantifying PRESS-acquired metabolite signals may cause errors because the frequency profiles of the 90 and 180 RF pulses used were not identical. However, because the difference in the profiles was not substantial [ie, transition width / bandwidth ffi 10% and 12%, respectively (14) ] and the water T 2 is different between tumors (28), the errors due to the profile discrepancy may be smaller than the errors that can be introduced when PRESS water signals at the shortest possible TE ($45 ms in the PRESS sequence used) are used as reference. Finally, use of a constant water concentration (43 M) for metabolite quantification can cause errors when the water concentration differs between tumors.
Comparison of 2HG detectability between 7T and 3T may be of interest. When comparing the present 7T data with 3T data, obtained with our previously reported PRESS TE ¼ 97 ms method (9,10), 7T appears to be advantageous over 3T for 2HG detection. For five patients who were scanned at both 7T and 3T with time intervals of less than 1 week, the mean estimates of 2HG and tCho were similar between 7T and 3T (2.9 versus 3.1 mM for 2HG, and 3.1 versus 3.2 mM for tCho). The mean 2HG CRLB was, however, quite different between 7T and 3T (5% and 8%, respectively), which is likely due to SNR difference (Supporting Fig. S5 ). When taking into account the differences in voxel size and scan durations, the mean SNR of tCho was higher by approximately 1.4 fold at 7T than at 3T although signal reduction due to T 2 relaxation effect is more extensive at 7T than at 3T (eg, tCho T 2 ffi 140 ms versus 230 ms, respectively). The higher SNR at 7T than at 3T may be due to signal gain at high field and difference in the signal reception coils (16 versus eight channels). Most importantly, the mutual dependence of 2HG and GABA signal estimation was markedly lower at 7T than at 3T, as indicated by the 2HG-GABA correlation coefficients returned by LCModel: maximum and minimum values over the five patients were À0.18 and 0.05, respectively, at 7T compared with À0.61 and À0.34, respectively, at 3T. These results demonstrate that the opposite polarity and apparent narrowing of 2HG and GABA signals, achieved using long TE at 7T, provide improved signal separation compared with 3T long-TE MRS that yields only line narrowing with respect to short TE (10).
In conclusion, noninvasive in vivo detection of elevated 2HG in IDH mutant gliomas has been largely demonstrated at low field strengths (3T) to date, where the SNR and spectral resolution of 2HG from GABA and Glu may be limited. Our proposed MRS method at 7T provides a new tool for reliable measurement of 2HG, with excellent separation of 2HG from neighboring resonances. With this 7T MRS, detection of 2HG in small tumor mass with low cellularity may be possible, which is challenging at low field strengths. The role of 2HG in IDH-mutated gliomas is well established as a diagnostic and prognostic tool (1, 6, 7) . Our prebiopsy 2HG measurement with good precision may provide great potential for noninvasive diagnosis of brain lesions. When used in conjunction with other imaging methods such as magnetic resonance angiography or susceptibility-weighted imaging, both of which show significant increase in resolution at 7T (29, 30) , 2HG MRS may provide new information on tumor metabolism and microenvironment. Several therapeutic studies are currently underway, targeting mutated forms of IDH1 and IDH2 (31, 32) . Noninvasive measurement of this unprecedented MRS biomarker 2HG may have great potential for drug development as well as for monitoring tumor progression and response to treatment (33) .
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article. Fig. S1 . Numerically calculated spectra of the 2HG C4-/C3-proton resonances are displayed versus the subecho times TE 1 and TE 2 of the PRESS sequence used in the study. Spectra were broadened to a singlet full-width half-maximum (FWHM) of 9 Hz. Fig. S2 . Numerically calculated PRESS (TE 1 , TE 2 ) 5 (58, 20) ms spectra of 2HG and GABA at equal concentrations are shown, together with an artificial singlet at 2.6 ppm (green), for various singlet line widths (FWHM). Spectra are normalized to the singlet in each FWHM. Fig. S3 . In vivo spectra from a healthy brain are shown together with LCModel outputs and individual spectra of 2HG and GABA from three brain regions (frontal, temporal, and posterior). 2HG was undetectable in all three spectra. The voxel size was 4.5 mL for frontal and temporal and 5.9 mL for posterior. Data were acquired with NSA 5 64. Fig. S5 . In vivo spectra at 7T and 3T from an IDH-mutated grade 2 astrocytoma patient are presented with LCModel outputs and spectra of 2HG and GABA. At 3T, the spectrum was acquired using a PRESS TE 5 97 ms method, and metabolite quantification was performed similarly to our previous study 9. Spectra were scaled with respect to short-TE water for each B 0 . The voxel size, TR, and NSA were 8 mL, 2.5 s, and 64, respectively, at 7T and 8 mL, 2 s, and 80, respectively, at 3T. Data were acquired using 16-and eight-channel coils at 7T and 3T, respectively, which were combined using an in-house channel combination method.
